Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.140
+0.010 (0.88%)
At close: Mar 23, 2026, 4:00 PM EDT
1.198
+0.058 (5.12%)
After-hours: Mar 23, 2026, 7:59 PM EDT
RANI Market Cap
RANI has a market cap or net worth of $111.2 million as of March 23, 2026. Its market cap has increased by 111.27% in one year.
Market Cap
111.20M
Enterprise Value
124.61M
1-Year Change
111.27%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on July 30, 2021, RANI's market cap has decreased from $206.13M to $111.20M, a decrease of -46.05%. That is a compound annual growth rate of -12.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 110.23M | -16.30% |
| Dec 31, 2025 | 131.69M | 188.57% |
| Dec 31, 2024 | 45.64M | -46.89% |
| Dec 29, 2023 | 85.92M | -41.09% |
| Dec 30, 2022 | 145.85M | -54.75% |
| Dec 31, 2021 | 322.29M | 56.36% |
| Jul 30, 2021 | 206.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Black Diamond Therapeutics | 120.88M |
| Sangamo Therapeutics | 111.62M |
| Innate Pharma | 109.65M |
| Inovio Pharmaceuticals | 109.17M |
| Aldeyra Therapeutics | 108.93M |
| Genelux | 107.53M |
| Oncolytics Biotech | 102.23M |
| Turn Therapeutics | 101.29M |